Health in Guatemala 1,197 indicators covering health for Guatemala. IndicatorLatest Year10-yr change Rank Earthquake deaths 3 2022 down 93.8% 26th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 81.0% 2025 — 111th International Health Regulations core capacity scores, SPAR version 30 2025 — 138th Prevalence of underweight, weight for age 14.4% 2021 up 2.1% 34th Leprosy registered prevalence rate per 1 000 000 population 0.163 2024 — 111th Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 3 2024 — 102nd New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Children (0-14) living with HIV 890 2024 down 44.4% 58th Ipv1 number unvaccinated 3,686 2023 down 81.8% 118th Children living with hiv 890 2024 down 44.4% 58th Contraceptive prevalence, any method 60.6% 2015 up 40.0% 48th Children (ages 0-14) newly infected with HIV 200 2024 unchanged 45th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 11.2% 2024 down 8.2% 116th Liver cancer death rate 14.33 2022 down 0.2% 3rd Number of children newly infected with hiv 200 2024 unchanged 45th Share of children under fifteen years old with hiv 108.02 2024 down 12.3% 50th Number of female leprosy new cases 0 2024 — 102nd Estimated number of malaria deaths 0 2024 down 100.0% 66th Estimated number of malaria cases 2,925 2024 down 49.3% 65th National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st Contraceptive prevalence, any modern method 48.9% 2015 up 42.2% 52nd Number of prevalent tuberculosis cases 17,000 2014 up 21.4% 63rd Estimated malaria incidence 0.2105 2024 down 56.8% 69th Estimated malaria mortality rate 0 2024 down 100.0% 66th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Proportion of total government spending on essential services, health 15.5% 2024 up 22.0% 25th Pancreatic cancer death rate 1.97 2022 down 27.5% 100th Brain and nervous system cancer death rate 1.29 2022 down 28.9% 100th Inflation-adjusted prices for most sold brand of cigarettes: Prices 5.8 2022 up 18.6% 101st Taxes as a % of price: total tax 49.0% 2022 unchanged 110th Taxes as a % of price: value added tax 10.7% 2022 unchanged 120th Taxes as a % of price: ad valorem excise 38.3% 2022 unchanged 28th Taxes as a % of price: specific excise 0.0% 2022 — 134th Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.0% 2022 — 56th Inflation-adjusted prices for most sold brand of cigarettes: Price in 22.5 2022 up 7.8% 105th Prevalence of severe wasting, weight for height 0.2% 2021 unchanged 75th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 99th Number of deaths from malaria who 0 2024 down 100.0% 66th Death rate from malaria 0 2024 down 100.0% 66th Incidence of malaria 0.21 2024 down 57.1% 68th Share of one year olds who received the final dose of pneumococcal vac 89 2024 up 43.5% 68th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 89 2024 up 43.5% 68th Death rate from poisonings 0.8 2021 down 27.3% 66th Mortality rate attributed to cardiovascular disease, cancer, diabetes 14.6 % 2021 down 0.7% 113th Mortality rate attributed to unintentional poisonings, by sex 0.8 per 100,000 people 2021 down 27.3% 60th Suicide mortality rate, by sex 4.9 per 100,000 people 2021 down 14.0% 116th Rotavirus number unvaccinated 33,178 2023 down 16.4% 50th Share of deaths registered 93.24 2019 — 89th Prevalence of stunting, height for age 46.0% 2021 down 10.7% 5th Affordability - percentage of GDP per capita required to purchase 5.84 2022 up 6.8% 59th Malaria cases reported 2,925 2024 down 40.7% 64th Deaths and missing persons due to natural disasters 1.6 2023 up 213.7% 49th Mean systolic blood pressure 119.1 2009 up 0.5% 168th Mean fasting blood glucose (mmol/l) 5.9 2009 up 5.4% 10th Hiv expenditure 60.88 million 2024 up 9.6% 31st ← Previous Page 17 of 20 Next →